Showing 1-5 of 10 partners:
OM1 and Medtronic Partner on Propel Study to Assess Long-term Outcomes for Patients With Chronic Rhinosinusitis

Utilizing clinical data from electronic health records related to endoscopic sinus surgeries, Medtronic and OM1 found PROPEL devices result in fewer postoperative care needs in chronic rhinosinusitis patients   April 09, 2024 09:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1, the leading AI and insights-driven technology and data company specializing in personalized medicine, evidence generation, and[…]

The 2023 PharmaVoice 100 Awards Dr. Carl Marci

PharmaVoice Sept. 19. 2023 Read the full article >> The mental health crisis in the U.S. has reached a fever pitch with an estimated one in five adults experiencing some form of mental illness, according to the NIH. For Dr. Carl Marci, the dire need for new mental health solutions has propelled him throughout his 30-year[…]

OM1 Appoints Shawn Bates as Chief Commercial Officer

BioPharma Dive Sept. 19, 2023 Read the full release >> BOSTON–(BUSINESS WIRE)–OM1, a leading real-world data, AI and technology company with a focus on chronic diseases, today announced the appointment of Shawn Bates as Chief Commercial Officer. Bates will work cross-functionally to steer OM1’s commercial strategy – including sales, marketing, and commercial operations – widening[…]

New mammography guidance throws another twist into screening debate

Axios Tina Reed May 10, 2023 Read the full article>> New guidelines changing the recommended screening age for breast cancer to 40 years old from 50 are adding another wrinkle to the confusing discussion over when and how often to get mammograms. Driving the news: The draft guidance the U.S. Preventive Services Task Force released on Tuesday for[…]

Dermatology Data Can Direct Policy Priorities, but Gaps Reflect Inequities of Care

American Journal of Managed Care Mar 17, 2023 Christina Mattina Read the Full Article >> Speakers at the American Academy of Dermatology 2023 Annual Meeting highlighted the potential of DataDerm to tell the story of dermatological care in the United States, but some also cautioned that the registry only reflects those who have access to[…]

1 2